Literature DB >> 203579

Correlation of type I, type II, and reverse type I difference spectra with absolute changes in spin state of hepatic microsomal cytochrome P-450 iron from five mammalian species.

K Kumaki, M Sato, H Kon, D W Nebert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 203579

Source DB:  PubMed          Journal:  J Biol Chem        ISSN： 0021-9258            Impact factor:   5.157


× No keyword cloud information.
  10 in total

1.  The effects of type II binding on metabolic stability and binding affinity in cytochrome P450 CYP3A4.

Authors:  Chi-Chi Peng; Josh T Pearson; Dan A Rock; Carolyn A Joswig-Jones; Jeffrey P Jones
Journal:  Arch Biochem Biophys       Date:  2010-03-25       Impact factor: 4.013

2.  Reverse type I binding spectra of human cytochrome P450 1B1 induced by flavonoid, stilbene, pyrene, naphthalene, phenanthrene, and biphenyl derivatives that inhibit catalytic activity: a structure-function relationship study.

Authors:  Tsutomu Shimada; Katsuhiro Tanaka; Shigeo Takenaka; Maryam K Foroozesh; Norie Murayama; Hiroshi Yamazaki; F Peter Guengerich; Masayuki Komori
Journal:  Chem Res Toxicol       Date:  2009-07       Impact factor: 3.739

3.  Drug modulation of water-heme interactions in low-spin P450 complexes of CYP2C9d and CYP125A1.

Authors:  Kip P Conner; Alex A Cruce; Matthew D Krzyaniak; Alina M Schimpf; Daniel J Frank; Paul Ortiz de Montellano; William M Atkins; Michael K Bowman
Journal:  Biochemistry       Date:  2015-01-29       Impact factor: 3.162

4.  CW EPR parameters reveal cytochrome P450 ligand binding modes.

Authors:  Molly M Lockart; Carlo A Rodriguez; William M Atkins; Michael K Bowman
Journal:  J Inorg Biochem       Date:  2018-02-24       Impact factor: 4.155

5.  Reverse type I inhibitor of Mycobacterium tuberculosis CYP125A1.

Authors:  Hugues Ouellet; Petrea M Kells; Paul R Ortiz de Montellano; Larissa M Podust
Journal:  Bioorg Med Chem Lett       Date:  2010-11-05       Impact factor: 2.823

6.  Crystal structures of cytochrome P450 105P1 from Streptomyces avermitilis: conformational flexibility and histidine ligation state.

Authors:  Lian-Hua Xu; Shinya Fushinobu; Haruo Ikeda; Takayoshi Wakagi; Hirofumi Shoun
Journal:  J Bacteriol       Date:  2008-12-12       Impact factor: 3.490

7.  Cytochrome P450 2C9 type II binding studies on quinoline-4-carboxamide analogues.

Authors:  Chi-Chi Peng; Jonathan L Cape; Tom Rushmore; Gregory J Crouch; Jeffrey P Jones
Journal:  J Med Chem       Date:  2008-12-25       Impact factor: 7.446

8.  Binding of a cyano- and fluoro-containing drug bicalutamide to cytochrome P450 46A1: unusual features and spectral response.

Authors:  Natalia Mast; Wenchao Zheng; C David Stout; Irina A Pikuleva
Journal:  J Biol Chem       Date:  2013-01-03       Impact factor: 5.157

9.  Cytochrome P-450 induction by clofibrate. Purification and properties of a hepatic cytochrome P-450 relatively specific for the 12- and 11-hydroxylation of dodecanoic acid (lauric acid).

Authors:  G G Gibson; T C Orton; P P Tamburini
Journal:  Biochem J       Date:  1982-04-01       Impact factor: 3.857

10.  In Vitro Activation of Cytochrome P450 46A1 (CYP46A1) by Efavirenz-Related Compounds.

Authors:  Natalia Mast; Peter Verwilst; Clayton J Wilkey; F Peter Guengerich; Irina A Pikuleva
Journal:  J Med Chem       Date:  2019-11-03       Impact factor: 7.446
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.